Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells, Cancer Res, vol.61, pp.5736-5776, 2001. ,
, , 2002.
, , 2002.
, VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is downregulated in renal cell carcinoma, Cancer Res, vol.62, pp.4123-4154
The endogenous anti-angiogenic family of splice variants of VEGF, VEGFxxxb, are downregulated in pre-eclamptic placentae at term, Clin Sci, vol.110, pp.575-85, 2006. ,
Angiogenesis in cancer and other diseases, Nature, vol.407, pp.249-57, 2000. ,
, , 2007.
, Increased expression of VEGF121/VEGF165-189 ratio results in a significant enhancement of human prostate tumor angiogenesis, Int J Cancer, vol.120, pp.2096-109
Tissue-specific expression pattern of vascular endothelial growth factor isoforms in the malignant transformation of lung and colon, Hum Pathol, vol.29, pp.910-914, 1998. ,
Sam68-like mammalian protein 2, identified by digital differential display as expressed by podocytes, is induced in proteinuria and involved in splice site selection of vascular endothelial growth factor, J Am Soc Nephrol, vol.16, pp.1958-65, 2005. ,
Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer, Cancer Res, vol.66, pp.11897-906, 2006. ,
Microenvironment Changes (in pH) Affect VEGF Alternative Splicing, Cancer Microenviron, vol.1, pp.131-140, 2008. ,
The biology of VEGF and its receptors, Nat Med, vol.9, pp.669-76, 2003. ,
Angiogenesis: an organizing principle for drug discovery?, Nat Rev Drug Discov, vol.6, pp.273-86, 2007. ,
The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neoangiogenesis, Nat Struct Mol Biol, vol.16, pp.1086-93, 2009. ,
, , 2004.
, Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer, N Engl J Med, vol.350, pp.2335-2377
, , 2005.
, Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer, J Clin Oncol, vol.23, pp.3502-3510
Neuropilin-1 is a direct target of the transcription factor E2F1 during cerebral ischemia-induced neuronal death in vivo, Mol Cell Biol, vol.27, pp.1696-705, 2007. ,
Vascular endothelial growth factor (VEGF)-A165b is a weak in vitro agonist for VEGF receptor-2 due to lack of coreceptor binding and deficient regulation of kinase activity, Cancer Res, vol.68, pp.4683-92, 2008. ,
Alternative splicing in angiogenesis: the vascular endothelial growth factor paradigm, Cancer Lett, vol.249, pp.133-175, 2007. ,
, , 2003.
, Expression of VEGF, semaphorin SEMA3F, and their common receptors neuropilins NP1
, NP2 in preinvasive bronchial lesions, lung tumours, and cell lines, J Pathol, vol.200, pp.336-383
E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35, Cell Death Differ, vol.15, pp.1815-1838, 2008.,
URL : https://hal.archives-ouvertes.fr/inserm-00360967
, , 2008.
, Expression of pro-and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors, J Cell Sci, vol.121, pp.3487-95
Regulation of vascular endothelial growth factor (VEGF) splicing from proangiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis, J Biol Chem, vol.285, pp.5532-5572, 2010. ,
E2F -at the crossroads of life and death, Trends Cell Biol, vol.18, pp.528-563, 2008. ,
, , 2007.
, Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma, Br J Cancer, vol.97, pp.223-253
Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF, 2006. ,
, Proc Natl Acad Sci U S A, vol.103, pp.11015-11035
Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis, Cancer Res, vol.55, pp.4575-80, 1995. ,
The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice, Br J Cancer, vol.98, pp.1250-1257, 2008. ,
The splice variants of vascular endothelial growth factor (VEGF) and their receptors, J Cell Sci, vol.114, pp.853-65, 2001. ,
, , pp.2-3, 2006.
, induces apoptosis and sensitizes human lung adenocarcinoma cells to death-receptor-mediated apoptosis through specific downregulation of c-FLIP(short), Cell Death Differ, vol.13, pp.260-72
E2F-1, Skp2 and cyclin E oncoproteins are upregulated and directly correlated in high-grade neuroendocrine lung tumors, Oncogene, vol.26, pp.6927-6963, 2007.,
URL : https://hal.archives-ouvertes.fr/inserm-00173067
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis, Nature, vol.359, pp.843-848, 1992. ,
VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro-and antiangiogenic VEGF-A isoforms has implications for therapy, Br J Cancer, vol.98, pp.1366-79, 2008. ,
, , 2004.
, VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression, Cancer Res, vol.64, pp.7822-7857
Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression, Cancer Res, vol.60, pp.3655-61, 2000. ,